Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kallol Purkait"'
Publikováno v:
CHIMIA, Vol 75, Iss 10, Pp 845-855 (2021)
Photodynamic therapy (PDT) is a remarkable alternative or complementary technique to chemotherapy, radiotherapy or immunotherapy to treat certain forms of cancer. The synergistic effect of light, photosensitizer (PS) and oxygen allows for the treatme
Externí odkaz:
https://doaj.org/article/58e8eb18845d406b9c7adc586016eefa
Autor:
Shantanu Saha Roy, Kallol Purkait, Arindam Mukherjee, Manas Pratim Chakraborty, Rahul Das, Moulinath Acharya, Souryadip Roy, Ayan Chakraborty, Tuhin Subhra Koley
Publikováno v:
Inorganic Chemistry. 60:18379-18394
Eight new ruthenium(II) complexes of N,N-chelating pyrazolylbenzimidazole ligands of the general formula [RuII(p-cym)(L)X]+ [where the ligand L is 2-(1H-pyrazol-1-yl)-1H-benzo[d]imidazole (L1) substituted at the 4 position of the pyrazole ring by Cl
Publikováno v:
Chemistry – An Asian Journal. 16:3729-3742
Half-sandwich RuII complexes, [(YZ)RuII (η6 -arene)(X)]+, (YZ=chelating bidentate ligand, X=halide), with N,N and N,O coordination (1-9) show significant antiproliferative activity against the metastatic triple-negative breast carcinoma (MDA-MB-231)
Autor:
Indira Bhattacharya, Arnab Gupta, Rishav Chatterjee, Arindam Mukherjee, Kallol Purkait, Tuhin Subhra Koley, Souryadip Roy
Publikováno v:
Inorganic Chemistry. 60:12172-12185
Morpholine motif is an important pharmacophore and, depending on the molecular design, may localize in cellular acidic vesicles. To understand the importance of the presence of pendant morpholine in a metal complex, six bidentate N,O-donor ligands wi
Publikováno v:
Inorganic Chemistry. 59:10262-10274
We report [RuII(L)(η6-p-cym)Cl] (1 and 2) and [PtII(L)(DMSO)Cl] (3 and 4) complexes, where L is a chelate imine ligand derived from chloroethylamine and salicylaldehyde (HL1) or o-vanillin (HL2). T...
Autor:
Sourav Acharya, Ashima Bhattacharjee, Kallol Purkait, Arpan Mukherjee, Arindam Mukherjee, Kaustav Chakraborty
Publikováno v:
Inorganic Chemistry. 59:6581-6594
Ruthenium compounds are promising anticancer candidates owing to their lower side-effects and encouraging activities against resistant tumors. Half-sandwich piano-stool type RuII compounds of general formula [(L)RuII(η6-arene)(X)]+ (L = chelating bi
Autor:
Arpan, Mukherjee, Tuhin Subhra, Koley, Ayan, Chakraborty, Kallol, Purkait, Arindam, Mukherjee
Publikováno v:
Chemistry, an Asian journal. 16(22)
Half-sandwich Ru
Autor:
Rishav, Chatterjee, Indira, Bhattacharya, Souryadip, Roy, Kallol, Purkait, Tuhin Subhra, Koley, Arnab, Gupta, Arindam, Mukherjee
Publikováno v:
Inorganic chemistry. 60(16)
Morpholine motif is an important pharmacophore and, depending on the molecular design, may localize in cellular acidic vesicles. To understand the importance of the presence of pendant morpholine in a metal complex, six bidentate N,O-donor ligands wi
Publikováno v:
Inorganic Chemistry. 58:15659-15670
Ruthenium(II/III) complexes are predicted to be efficient alternatives to platinum drug-resistant cancers but have never been investigated for sequestration and efflux by Cu-ATPases (ATP7A or ATP7B) overexpressed in resistant cancer cells, although a
Publikováno v:
Inorganic Chemistry. 58:9213-9224
Four trimethoxy- and dimethoxyphenylamine-based Schiff base (L1-L4)-bearing RuII-p-cymene complexes (1-4) of the chemical formula [RuII(η6-p-cymene)(L)(Cl)] were synthesized, isolated in pure form, and structurally characterized using single-crystal